Lower Inflammation, Stronger Cells Chronic, low-grade inflammation is a driver of aging
Phase 2 Type 2 Diabetes Trial Rosenstock et al., The Lancet (2023) Rosenstock and colleagues conducted a phase 2, randomized, double-blind, double-dummy, placebo-controlled and active-comparator-controlled, parallel-group trial of retatrutide in adults with type 2 diabetes
Every claim is verifiable
Following centrifugation at 10.000 g for 15 min at 4 C, the resulting supernatant was collected for the determination of IL-1, TGF-, MMP-2, MMP-9 and TIMP-1
A glucose target of 7 may do better if their glucose is allowed to drift higher (up to ~250 mg/dL)(13.9 mM). When in doubt, dose insulin conservatively
Protective role of IGF1 and GLP1 signaling activation in neurological dysfunctions